Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02232373Not ApplicableTerminated
Campylobacter Enteritis and PI-BD: Dietary Reduction in Carbohydrates
Functional Gastrointestinal DisordersPost-infective Bowel Dysfunction
Principalinvestigator

Research Network

Collaboration Network

6 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mathew Diggle, MSc PhD

Nottingham University Hospitals NHS Trust

Related
1 trials

Shared therapeutic areas:

Campylobacter InfectionsIrritable Bowel Syndrome

Worked with same sponsors:

Department of Health, United KingdomKing's College London+3 more
Collaborated on 1 trial
Similarity Score24%

Richard Puleston, MBBS PhD

University of Nottingham

Related
1 trials

Shared therapeutic areas:

Campylobacter InfectionsIrritable Bowel Syndrome

Worked with same sponsors:

Department of Health, United KingdomKing's College London+3 more
Collaborated on 1 trial
Similarity Score24%

Miranda Lomer, PhD RD

King's College London

Related
1 trials

Shared therapeutic areas:

Campylobacter InfectionsIrritable Bowel Syndrome

Worked with same sponsors:

Department of Health, United KingdomKing's College London+3 more
Collaborated on 1 trial
Similarity Score24%

Robin C Spiller, MSc MD FRCP

University of Nottingham

Related
1 trials

Shared therapeutic areas:

Campylobacter InfectionsIrritable Bowel Syndrome

Worked with same sponsors:

Department of Health, United KingdomKing's College London+3 more
Collaborated on 1 trial
Similarity Score24%

Robin C Spiller, PhD FRCP

University of Nottingham

Related
1 trials

Shared therapeutic areas:

Functional Gastrointestinal DisordersPost-infective Bowel Dysfunction

Worked with same sponsors:

King's College LondonNottingham University Hospitals NHS Trust+1 more
Collaborated on 1 trial
Similarity Score24%

Zhao-xiang Bian, PhD

Hong Kong Baptist University

Related
6 trials

Shared therapeutic areas:

Functional Gastrointestinal DisordersIrritable Bowel Syndrome
Similarity Score15%

Madhusudan Grover, MBBS

Mayo Clinic

Related
7 trials

Shared therapeutic areas:

Irritable Bowel SyndromeCampylobacter Infections
Similarity Score15%

William E Whitehead, PhD

University of North Carolina, Chapel Hill

Related
6 trials

Shared therapeutic areas:

Irritable Bowel Syndrome
Similarity Score8%

Georges Paizis, MD

Sanofi

Related
7 trials

Shared therapeutic areas:

Irritable Bowel Syndrome
Similarity Score8%

John K. DiBaise, M.D.

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Irritable Bowel Syndrome
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02040922PrincipalInvestigator

Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota

Campylobacter InfectionsIrritable Bowel Syndrome
Unknown
NCT02232373Not ApplicablePrincipalInvestigator

Campylobacter Enteritis and PI-BD: Dietary Reduction in Carbohydrates

Functional Gastrointestinal DisordersPost-infective Bowel Dysfunction
Terminated

All 2 trials loaded